| Literature DB >> 33841616 |
Andres Luque1, Aida Paola Rojas1, Andrea Ortiz-Florez1, Juliana Perez-Bernal1.
Abstract
Botulinum toxin has been used to treat persistent erythema and flushing in rosacea for several years. Here, we describe two women and one man, each with rosacea with flushing and permanent erythema refractory to conventional treatment, who achieved satisfactory and lasting results following intradermal application of botulinum toxin. Two different botulinum toxin types were used. Toxin concentrations of 3.75U per 0.1 mL (abobotulinum) and 1.25U per 0.1 mL (incobotulinum) were used for each patient were used for each patient. The outcomes were measured using polarized photography to evaluate the decrease in vascular involvement. In the three cases presented here, botulinum toxin was effective for controlling erythema and flushing associated with rosacea; we also observed a prolonged duration of these improvements without the rebound effect of topical therapies.Entities:
Keywords: Botulinum toxin; erythema; flushing; rosacea
Year: 2021 PMID: 33841616 PMCID: PMC8021409
Source DB: PubMed Journal: J Clin Aesthet Dermatol ISSN: 1941-2789